eISSN 2508-3589
pISSN 2508-1926

Table. 4.

Table. 4.

Pathologies in the three study groups who have confirmed by pathologic examination

Group 1 (16)Group 2 (18)Group 3 (15)Total (49)p-value
Malignant5 (31.3)10 (55.6)14 (93.3)29 (59.2)0.001*
 Malignant melanoma5 (31.3)9 (50.0)14 (93.3)28 (57.1)0.001*
  Epithelioid2 (12.5)3 (16.7)4 (26.7)9 (18.4)0.086
  Mixed1 (6.3)0 (0.0)3 (20.0)6 (12.2)
  Spindle0 (0.0)4 (22.2)2 (13.3)5 (10.2)
 Squamous cell carcinoma0 (0.0)1 (5.6)0 (0.0)1 (2.0)1.000
Benign11 (68.8)8 (44.4)1 (6.7)20 (40.8)
 Adenoma4 (25.0)2 (11.1)0 (0.0)6 (12.2)0.117
 Leiomyoma1 (6.3)4 (22.2)1 (6.7)6 (12.2)0.342
 Nevus1 (6.3)0 (0.0)0 (0.0)1 (2.0)0.633
 Melanocytoma3 (18.8)0 (0.0)0 (0.0)3 (6.1)0.055
 Schwannoma0 (0.0)1 (5.6)0 (0.0)1 (2.0)1.000
 Neurogenic tumor0 (0.0)1 (5.6)0 (0.0)1 (2.0)1.000
 Non-teratoid medulloepithelioma1 (6.3)0 (0.0)0 (0.0)1 (2.0)0.633
 Fibrosis with pigment1 (6.3)0 (0.0)0 (0.0)1 (2.0)0.633

Values are presented as number (%).

Chi-square test;

Fisher’s exact test.

Korean J Ret 2019;4:23-31 https://doi.org/10.21561/jor.2019.4.1.23
© 2019 Korean J Ret